Cellectar Biosciences, Inc.
CLRB · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G ·
Latest disclosures
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Loren Stefan: Form 4/A
Insider disclosure · Filed · Report period 08 Jul 2026
-
Form 4/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001279704 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CLRB on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 100 Campus Drive, Florham Park, NJ, 07932
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- NOVELOS THERAPEUTICS, INC. (to 11 Feb 2014), COMMON HORIZONS INC (to 02 Jun 2005)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields